Sciclone Pharmaceuticals Holdings Ltd.

The deals mark the eighth and ninth in past five years for programs targeting PD-L1 family members B7-H3, B7-H4 

New data from EpicentRx boost confidence in NLRP3 as a cancer target, with a pair of autoimmune programs not far behind 

Plus Protano named CFO at Alltrna, and updates from Laronde, Xentria and more

Plus new CFO, CMO at Renibus, and updates from Bayer, Gilead, Shionogi and more

Megaround for cross-border cell therapy company follows privatization led by Tony Liu

How the Chinese in-licensing play plans to become a global specialty pharma

DISEASE CATEGORY: Infectious disease
INDICATION: Sepsis Inhibiting the scaffold protein SQSTM1 or its extracellular receptor INSR could treat bacterial sepsis. Among 40 patients with bacterial

An overview of how therapies in clinical trials for coronavirus interfere with viral biology